Literature DB >> 3345316

Toxins from the venom of the green mamba Dendroaspis angusticeps that inhibit the binding of quinuclidinyl benzilate to muscarinic acetylcholine receptors.

A Adem1, A Asblom, G Johansson, P M Mbugua, E Karlsson.   

Abstract

Two protein toxins that displace the muscarinic antagonist quinuclidinyl benzilate from rat cortex synaptosomal membranes have been isolated from the green mamba (Dendroaspis angusticeps) venom by gel filtration on sephadex G-50, chromatography on the ion-exchangers Bio-Rex 70 and Sulphopropyl-Sephadex C-25 and reversed-phase HPLC. Toxin 1 has 64 amino acids and four disulfides and a formula weight of 7200 and the corresponding values for toxin 2 are 63, 4 and 6840, respectively. Ultracentrifugation gave a molecular weight of 6900 for toxin 1 and 6700 for toxin 2, Quinuclidinyl benzilate that binds to all types of muscarinic cholinergic receptor was displaced to about 50% by both toxins. This partial displacement indicates that the toxins might be specific for one subtype of receptor.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3345316     DOI: 10.1016/0167-4889(88)90025-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

1.  Adrenoceptor activity of muscarinic toxins identified from mamba venoms.

Authors:  K Näreoja; J P Kukkonen; S Rondinelli; D M Toivola; J Meriluoto; J Näsman
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

2.  Coralsnake Venomics: Analyses of Venom Gland Transcriptomes and Proteomes of Six Brazilian Taxa.

Authors:  Steven D Aird; Nelson Jorge da Silva; Lijun Qiu; Alejandro Villar-Briones; Vera Aparecida Saddi; Mariana Pires de Campos Telles; Miguel L Grau; Alexander S Mikheyev
Journal:  Toxins (Basel)       Date:  2017-06-08       Impact factor: 4.546

3.  Interaction of synthetic peptides from fasciculin with acetylcholinesterase.

Authors:  R J Falkenstein; C Peña
Journal:  J Protein Chem       Date:  1999-02

4.  Identification of a novel snake peptide toxin displaying high affinity and antagonist behaviour for the α2-adrenoceptors.

Authors:  Céline Rouget; Loïc Quinton; Arhamatoulaye Maïga; Céline Gales; Geoffrey Masuyer; Christian Malosse; Julia Chamot-Rooke; Robert Thai; Gilles Mourier; Edwin De Pauw; Nicolas Gilles; Denis Servent
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

5.  Inhibition of acetylcholine muscarinic M(1) receptor function by the M(1)-selective ligand muscarinic toxin 7 (MT-7).

Authors:  M C Olianas; C Maullu; A Adem; E Mulugeta; E Karlsson; P Onali
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

6.  Soluble monomeric acetylcholinesterase from mouse: expression, purification, and crystallization in complex with fasciculin.

Authors:  P Marchot; R B Ravelli; M L Raves; Y Bourne; D C Vellom; J Kanter; S Camp; J L Sussman; P Taylor
Journal:  Protein Sci       Date:  1996-04       Impact factor: 6.725

7.  The detection of the non-M2 muscarinic receptor subtype in the rat heart atria and ventricles.

Authors:  Jaromir Myslivecek; Martin Klein; Martina Novakova; Jan Ricny
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-04-29       Impact factor: 3.000

8.  Effects of muscarinic toxins MT1 and MT2 from green mamba on different muscarinic cholinoceptors.

Authors:  Alan L Harvey; Edgar Kornisiuk; Karen N Bradley; Carlos Cerveñansky; Rosario Durán; Martin Adrover; Gonzalo Sánchez; Diana Jerusalinsky
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

9.  Rat striatal muscarinic receptors coupled to the inhibition of adenylyl cyclase activity: potent block by the selective m4 ligand muscarinic toxin 3 (MT3).

Authors:  M C Olianas; A Adem; E Karlsson; P Onali
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

10.  Molecular conversion of muscarinic acetylcholine receptor M(5) to muscarinic toxin 7 (MT7)-binding protein.

Authors:  Sergio Rondinelli; Katja Näreoja; Johnny Näsman
Journal:  Toxins (Basel)       Date:  2011-11-11       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.